Cardiac Disorders Associated with Cellular Therapy and Novel Agents for Acute Leukemia.
Isr Med Assoc J
; 24(3): 170-174, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-35347930
ABSTRACT
BACKGROUND:
Several novel strategies have emerged in the last decade as potential therapies for patients with chemorefractory lymphoproliferative diseases and acute leukemia. While these treatments include exciting drugs that dramatically change the landscape of treatment, the organ-toxicity profile associated with these therapies may be significant. This article focuses on cardiac disorders associated with chimeric antigen receptor T-cell (CAR-T) therapy, as well as with novel regimens for acute leukemia.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Leucemia
/
Cardiopatías
/
Trastornos Linfoproliferativos
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Isr Med Assoc J
Asunto de la revista:
MEDICINA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Israel